Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症超过急性足痛风的病人了，并且秋水仙素腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服素是不恰当的，很少有炎症急性足痛风的病人了，并且素导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口秋水仙素是不恰当的，很少有炎症能超过急风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙是不恰当的，很少有炎症超过急性足痛风的病人了，并且秋水仙致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始秋水仙碱治疗效果不明显转氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰的，很少有炎症能超过急性的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么，在开始受秋水疗效果不明显转而受氨苯砜疗的患者应当继续服用秋水。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口秋水仙素是不恰当的，很少有炎症能超过急风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口秋水仙素是不恰当的，很少有炎症能超过急风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当用秋水仙碱。